Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCA-ALS phase 3 trial in amyotrophic lateral sclerosis
NL-OMON55527Phase 3Completed
- Sponsor
- Humanitas Research Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tauroursodeoxycholic acid in amyotrophic lateral sclerosis (ALS), sponsored by Humanitas Research Hospital. Started Dec 2019; status: completed.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on NL-OMON55527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON55527.